Header Logo

Peter N Johnson

TitleProf
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentPharmacy Clinical & Admin Sci
AddressCPB 206
1110 N Stonewall Ave
Oklahoma City OK 73117
Phone405/271-2730
Fax0
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Miller JL, Stephens K, Johnson PN, Medina M. Teaching residents how to deliver active learning during didactic lectures. Am J Health Syst Pharm. 2021 05 24; 78(11):944-948. PMID: 33755109.
      Citations:    Fields:    
    2. Nguyen AL, Johnson PN, Neely SB, Hughes KM, Sekar KC, Welliver RC, Miller JL. Comparison of Amikacin Pharmacokinetics in Neonates With and Without Congenital Heart Disease. J Pediatr Pharmacol Ther. 2021; 26(4):372-378. PMID: 34035682.
      Citations:    
    3. Lim SY, Miller JL, Henry E, Heltsley R, Woo S, Johnson PN. Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children. Pharmacotherapy. 2021 Apr; 41(4):359-369. PMID: 33604895.
      Citations: 1     Fields:    
    4. Harkin M, Miller JL, Lim SY, Neely SB, Walsh CK, Johnson PN. Conversion From Continuous Infusion Fentanyl to Continuous Infusion Hydromorphone in the Pediatric Intensive Care Unit. Ann Pharmacother. 2021 Mar 20; 10600280211003170. PMID: 33745290.
      Citations:    Fields:    
    5. Miller JL, Lewis TV, Walling J, O'Donnell A, Neely SB, Johnson PN. Publication Rates of Pediatric-Focused Resident Research Projects Presented at The Pediatric Pharmacy Association Bruce Parks Memorial Residency Showcase. J Pediatr Pharmacol Ther. 2021; 26(2):163-171. PMID: 33603580.
      Citations:    
    6. Harkin M, Johnson PN, Neely SB, White L, Miller JL. Frequency and Severity of Chlorothiazide-Induced Hyponatremia in the Neonatal Intensive Care Unit. Am J Perinatol. 2021 Jan 06. PMID: 33406536.
      Citations:    Fields:    
    7. Harkin M, Shaddix BP, Neely SB, Peek LA, Stephens K, Barker P, McMullan L, Gormley A, Johnson PN. Evaluation of dosing and safety outcomes of low-dose prophylactic warfarin in children after cardiothoracic surgery. Am J Health Syst Pharm. 2020 06 23; 77(13):1018-1025. PMID: 32470108.
      Citations:    Fields:    Translation:Humans
    8. Nguyen TT, Bergeron E, Lewis TV, Miller JL, Hagemann TM, Neely S, Johnson PN. Descriptive study of discharge medications in pediatric patients. SAGE Open Med. 2020; 8:2050312120927945. PMID: 32547752.
      Citations:    
    9. Shaddix BP, Harkin M, Miller JL, Johnson PN. Which PGY1 Pharmacy Residency Is Right for Me? Advantages and Disadvantages of Pediatric-Focused and Traditional PGY1 Pharmacy Programs. J Pediatr Pharmacol Ther. 2020; 25(4):273-277. PMID: 32461739.
      Citations:    
    10. Capino AC, Thomas AN, Baylor S, Hughes KM, Miller JL, Johnson PN. Antipsychotic Use in the Prevention and Treatment of Intensive Care Unit Delirium in Pediatric Patients. J Pediatr Pharmacol Ther. 2020; 25(2):81-95. PMID: 32071582.
      Citations:    
    11. Lim SY, Woo S, Miller JL, Skrepnek GH, Henry ED, Johnson PN. Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children. Pediatr Crit Care Med. 2019 12; 20(12):e556-e564. PMID: 31568259.
      Citations:    Fields:    Translation:Humans
    12. Johnson PN, Gildon BL, Condren M, Miller JL, Hagemann TM, Lewis TV, John B, Farmer K. A survey of pediatric degree option program graduates in a doctor of pharmacy curriculum: Confidence and initial employment position. Curr Pharm Teach Learn. 2019 Dec; 11(12):1296-1302. PMID: 31836156.
      Citations:    Fields:    Translation:Humans
    13. Stephens K, Miller JL, Lewis TV, Neely S, Johnson PN. Hyponatremia With Intravenous Sulfamethoxazole/Trimethoprim in Children. Ann Pharmacother. 2020 04; 54(4):351-358. PMID: 31694388.
      Citations:    Fields:    Translation:Humans
    14. Johnson PN, Miller JL. Small patients, big problems? Pediatric primer for the nonpediatric pharmacist. Am J Health Syst Pharm. 2019 09 16; 76(19):1451-1452. PMID: 31436788.
      Citations:    Fields:    Translation:Humans
    15. Johnson PN, Stephens K, Barker P, Bergeron E, Lim SY, Hagemann TM, Lewis TV, Neely S, Miller JL. Prescribing Patterns of Continuous Infusions in Nonobese versus Obese Children Admitted to the Pediatric Intensive Care Unit. J Pediatr Intensive Care. 2019 Dec; 8(4):226-232. PMID: 31673458.
      Citations:    
    16. Miller JL, Johnson PN, White BP, Neely SB, Chaaban H, Kassa N, Welliver RC. Impact of Ceftazidime Use on Susceptibility Patterns in the Neonatal Intensive Care Unit. Pediatr Infect Dis J. 2019 06; 38(6):605-607. PMID: 30489466.
      Citations:    Fields:    Translation:HumansCells
    17. Blackmer AB, Siu A, Thornton A, Johnson PN, Nichols KR, Hagemann TM. Academic Careers in Pediatric Pharmacy: Part 2-Academic Advancement. J Pediatr Pharmacol Ther. 2019 May-Jun; 24(3):183-193. PMID: 31093017.
      Citations:    
    18. Miller JL, Ernst K, Neely SB, Stephens K, Barker P, Skrepnek GH, Johnson PN. Low-dose versus high-dose methadone for the management of neonatal abstinence syndrome. J Opioid Manag. 2019 Mar/Apr; 15(2):159-167. PMID: 31343717.
      Citations: 1     Fields:    Translation:Humans
    19. Siu A, Blackmer AB, Thornton AM, Johnson PN, Nichols KR, Hagemann TM. Overview and Preparation Guide for Academic Careers in Pediatric Pharmacy, Part 1: Career as a Pediatric Pharmacy Practice Faculty Member. J Pediatr Pharmacol Ther. 2019 Mar-Apr; 24(2):79-89. PMID: 31019400.
      Citations:    
    20. Capino AC, Johnson PN, Williams PK, Anderson MP, Bedwell S, Miller JL. Pilot Study Comparing Modified Finnegan Scoring Versus Adjusted Scoring System for Infants With Iatrogenic Opioid Abstinence Syndrome After Cardiothoracic Surgery. J Pediatr Pharmacol Ther. 2019 Mar-Apr; 24(2):148-155. PMID: 31019408.
      Citations:    
    21. Matson KL, Johnson PN, Tran V, Horton ER, Sterner-Allison J. Opioid Use in Children. J Pediatr Pharmacol Ther. 2019 Jan-Feb; 24(1):72-75. PMID: 30837819.
      Citations:    
    22. Johnson PN, Mitchell-Van Steele A, Nguyen AL, Stoffella S, Whitmore JM. Pediatric Pharmacists' Participation in Cardiopulmonary Resuscitation Events. J Pediatr Pharmacol Ther. 2018 Nov-Dec; 23(6):502-506. PMID: 30697139.
      Citations:    
    23. Dannelley JF, Johnson PN, Anderson MP, Oestreich K, Siatkowski RM, Miller JL. Assessment of Outcomes With a Sedation Protocol During Laser Photocoagulation in Preterm Infants With Retinopathy of Prematurity. J Pediatr Pharmacol Ther. 2018 Sep-Oct; 23(5):410-416. PMID: 30429696.
      Citations:    
    24. Lim SY, Woo S, Miller JL, Lewis TV, Henry ED, Johnson PN. Dosing for Fentanyl Infusion in Obese Children: Just Because It's What We Have Always Done Doesn't Mean It Is Right. J Pediatr Pharmacol Ther. 2018 May-Jun; 23(3):223-226. PMID: 29970980.
      Citations:    
    25. Johnson PN, Gildon BL, Condren M, Miller JL, Hagemann TM, Lewis TV, John B, Farmer K. Description of a pediatric degree option program in a doctorate of pharmacy curriculum and its impact on pediatric-focused advanced pharmacy practice experience rotations and faculty scholarly productivity. Curr Pharm Teach Learn. 2018 05; 10(5):627-636. PMID: 29986823.
      Citations: 1     Fields:    Translation:Humans
    26. Miller JL, Capino AC, Thomas A, Couloures K, Johnson PN. Sedation and Analgesia Using Medications Delivered via the Extravascular Route in Children Undergoing Laceration Repair. J Pediatr Pharmacol Ther. 2018 Mar-Apr; 23(2):72-83. PMID: 29720907.
      Citations:    
    27. Miller JL, Johnson PN, Harkey K, Siatkowski RM. Sedation Protocol During Bevacizumab Intravitreal Injection in Preterm Infants With Retinopathy of Prematurity. J Pediatr Pharmacol Ther. 2018 Jan-Feb; 23(1):34-40. PMID: 29491750.
      Citations:    
    28. Miller JL, Lepa TM, Ranallo C, Chaaban H, Skrepnek GH, Johnson PN. Detectable Concentrations of Inhaled Tobramycin in Critically Ill Children Without Cystic Fibrosis: Should Routine Monitoring Be Recommended? Pediatr Crit Care Med. 2017 Dec; 18(12):e615-e620. PMID: 29206744.
      Citations:    Fields:    Translation:Humans
    29. Jones AN, Miller JL, Neely S, Ibach BW, Hagemann TM, Golding CL, Lewis TV, Peek LA, Johnson PN. Prevalence of Unrounded Medication Doses and Associated Factors Among Hospitalized Pediatric Patients. J Pediatr Pharmacol Ther. 2017 Jul-Aug; 22(4):286-292. PMID: 28943824.
      Citations:    
    30. Johnson PN, Skrepnek GH, Golding CL, Owora AH, Thomas AN, Miller JL. Relationship between rate of fentanyl infusion and time to achieve sedation in nonobese and obese critically ill children. Am J Health Syst Pharm. 2017 Aug 01; 74(15):1174-1183. PMID: 28588011.
      Citations: 2     Fields:    Translation:Humans
    31. Duncan-Azadi CR, Johnson PN, Gormley A. Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient. A A Case Rep. 2017 May 01; 8(9):242-245. PMID: 28181946.
      Citations: 2     Fields:    Translation:Humans
    32. Johnson PN, Nguyen A, Neely SB, Johnson M. Intramuscular Lorazepam for Status Epilepticus in Children With Complex Medical and Physical Disabilities. Ann Pharmacother. 2017 Aug; 51(8):656-662. PMID: 28438026.
      Citations:    Fields:    Translation:Humans
    33. Hughes KM, Johnson PN, Anderson MP, Sekar KC, Welliver RC, Miller JL. Comparison of Amikacin Pharmacokinetics in Neonates Following Implementation of a New Dosage Protocol. J Pediatr Pharmacol Ther. 2017 Jan-Feb; 22(1):33-40. PMID: 28337079.
      Citations:    
    34. Capino AC, Miller JL, Johnson PN. Clonidine for Sedation and Analgesia and Withdrawal in Critically Ill Infants and Children. Pharmacotherapy. 2016 12; 36(12):1290-1299. PMID: 27779775.
      Citations: 3     Fields:    Translation:Humans
    35. Liedtke MD, Tomlin CR, Skrepnek GH, Farmer KC, Johnson PN, Rathbun RC. HIV Pharmacist's Impact on Inpatient Antiretroviral Errors. HIV Med. 2016 11; 17(10):717-723. PMID: 27038405.
      Citations: 5     Fields:    Translation:Humans
    36. Van Tuyl JS, Jones AN, Johnson PN. Meropenem-Induced Neutropenia in a Neonate. J Pediatr Pharmacol Ther. 2016 Jul-Aug; 21(4):353-357. PMID: 27713676.
      Citations:    
    37. Ibach BW, Miller JL, Woo S, Harrison D, Standifer KM, Hagemann T, Johnson PN. Characterization of Tolerance in Children during Fentanyl Continuous Infusions. J Pediatr Intensive Care. 2017 Jun; 6(2):83-90. PMID: 31073429.
      Citations:    
    38. Johnson PN, Miller JL, Hagemann TM, Moffett BS. Assessment of inpatient admissions and top 25 medications for obese pediatric patients at two academic hospitals. Am J Health Syst Pharm. 2016 Aug 15; 73(16):1243-9. PMID: 27354039.
      Citations: 2     Fields:    Translation:Humans
    39. Ibach BW, Henry ED, Johnson PN. Acute Kidney Injury in a Child Receiving Vancomycin and Piperacillin/Tazobactam. J Pediatr Pharmacol Ther. 2016 Mar-Apr; 21(2):169-75. PMID: 27199625.
      Citations:    
    40. Johnson PN, Miller JL, Ranallo C. Dosing of Vasopressin in Critically Ill Children: Implications for Medication Safety. Pediatr Crit Care Med. 2016 Mar; 17(3):277-8. PMID: 26945208.
      Citations:    Fields:    Translation:Humans
    41. Golding CL, Miller JL, Gessouroun MR, Johnson PN. Ketamine Continuous Infusions in Critically Ill Infants and Children. Ann Pharmacother. 2016 Mar; 50(3):234-41. PMID: 26783355.
      Citations: 6     Fields:    Translation:Humans
    42. Benefield EC, Hagemann TM, Allen HC, Farmer K, Burton ME, Chavez-Bueno S, Johnson PN. Vancomycin Dosing and Pharmacokinetics in Postoperative Pediatric Cardiothoracic Surgery Patients. J Pediatr Pharmacol Ther. 2016 Jan-Feb; 21(1):66-74. PMID: 26997930.
      Citations:    
    43. Thomas A, Miller JL, Couloures K, Johnson PN. Non-Intravenous Sedatives and Analgesics for Procedural Sedation for Imaging Procedures in Pediatric Patients. J Pediatr Pharmacol Ther. 2015 Nov-Dec; 20(6):418-30. PMID: 26766932.
      Citations:    
    44. Boucher EA, Burke MM, Johnson PN, Klein KC, Miller JL. Minimum Requirements for Core Competency in Pediatric Pharmacy Practice. J Pediatr Pharmacol Ther. 2015 Nov-Dec; 20(6):481-4. PMID: 26766938.
      Citations:    
    45. Ibach BW, Loeber C, Shukry M, Hagemann TM, Harrison D, Johnson PN. Duration of intrathecal morphine effect in children with idiopathic scoliosis undergoing posterior spinal fusion. J Opioid Manag. 2015 Jul-Aug; 11(4):295-303. PMID: 26312956.
      Citations: 2     Fields:    Translation:Humans
    46. Miller MM, Burton ME, Johnson PN, Miller JL. "Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology. Am J Health Syst Pharm. 2014 Dec 15; 71(24):2108-9. PMID: 25465576.
      Citations:    Fields:    Translation:Humans
    47. Miller MM, Johnson PN, Hagemann TM, Carter SM, Miller JL. Pseudohyperphosphatemia in children treated with liposomal amphotericin B. Am J Health Syst Pharm. 2014 Sep 01; 71(17):1462-8. PMID: 25147170.
      Citations: 1     Fields:    Translation:Humans
    48. Miller JL, Thomas AN, Johnson PN. Use of continuous-infusion loop diuretics in critically ill children. Pharmacotherapy. 2014 Aug; 34(8):858-67. PMID: 24897942.
      Citations: 3     Fields:    Translation:Humans
    49. Chandler CJ, Cunnyngham C, Miller J, Johnson PN. Propylene glycol-induced lactic acidosis in a child receiving a pentobarbital continuous infusion. J Pediatr Intensive Care. 2014 Jun; 3(2):73-77. PMID: 31214454.
      Citations:    
    50. Miller JL, Schaefer J, Tam M, Harrison DL, Johnson PN. Ethacrynic Acid continuous infusions in critically ill pediatric patients. J Pediatr Pharmacol Ther. 2014 Jan; 19(1):49-55. PMID: 24782692.
      Citations:    
    51. Lammers EM, Johnson PN, Ernst KD, Hagemann TM, Lawrence SM, Williams PK, Anderson MP, Miller JL. Association of fentanyl with neurodevelopmental outcomes in very-low-birth-weight infants. Ann Pharmacother. 2014 Mar; 48(3):335-42. PMID: 24311724.
      Citations: 5     Fields:    Translation:Humans
    52. Johnson PN, Miller JL, Hagemann TM, Castro C, Harrison D. External validation of the medication taper complexity score for methadone tapers in children with opioid abstinence syndrome. Ann Pharmacother. 2014 Feb; 48(2):187-95. PMID: 24259650.
      Citations:    Fields:    Translation:Humans
    53. Johnson PN, Benefield EC, Bui PY, Marlar RA, Gessouroun MR. Fondaparinux in an obese child with heparin-induced thrombocytopenia and a history of renal failure. J Pediatr Pharmacol Ther. 2013 Oct; 18(4):303-10. PMID: 24719591.
      Citations:    
    54. Johnson PN, Benefield EC, Bui PY, Gausman JN, Marlar RA, Gessouroun MR. Fondaparinux Monitoring: Need for a Local Fondaparinux-Calibrated Anti-F actor Xa Assay. J Pediatr Pharmacol Ther. 2013 Oct; 18(4):318-9. PMID: 24719594.
      Citations:    
    55. Andrews MG, Johnson PN, Lammers EM, Harrison DL, Miller JL. Acetazolamide in critically ill neonates and children with metabolic alkalosis. Ann Pharmacother. 2013 Sep; 47(9):1130-5. PMID: 24259727.
      Citations: 5     Fields:    Translation:Humans
    56. Andrews MG, Miller JL, Allen C, Hagemann TM, Harrison DL, Johnson PN. Implementation of a bowel regimen protocol in critically ill children: A pilot study. J Pediatr Intensive Care. 2013 Jun; 2(2):63-69. PMID: 31214425.
      Citations:    
    57. Johnson PN, Miller JL, Hagemann TM. Sedation and analgesia in critically ill children. AACN Adv Crit Care. 2012 Oct-Dec; 23(4):415-34; quiz 435-6. PMID: 23095967.
      Citations: 5     Fields:    Translation:Humans
    58. Bulkley CF, Johnson PN, Henry E, Harrison D, Lewis TV, Miller JL. Bumetanide continuous-infusion dosing in critically ill pediatric patients. Am J Health Syst Pharm. 2012 Sep 01; 69(17):1458, 1460-1. PMID: 22899737.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    59. Johnson PN, Miller J, Harrison D. Evaluation of initial methadone dosing for prevention of iatrogenic opioid abstinence syndrome in children. J Pediatr Intensive Care. 2012 Jun; 1(2):105-113. PMID: 31214394.
      Citations:    
    60. Johnson PN, Boyles KA, Miller JL. Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children. Pharmacotherapy. 2012 Feb; 32(2):148-57. PMID: 22392424.
      Citations: 7     Fields:    Translation:Humans
    61. Johnson PN, Harrison DL, Castro CH, Miller JL. A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home. Res Social Adm Pharm. 2012 Sep-Oct; 8(5):455-63. PMID: 22222345.
      Citations:    Fields:    Translation:Humans
    62. Miller M, Miller JL, Hagemann TM, Harrison D, Chavez-Bueno S, Johnson PN. Vancomycin dosage in overweight and obese children. Am J Health Syst Pharm. 2011 Nov 01; 68(21):2062-8. PMID: 22011985.
      Citations: 14     Fields:    Translation:Humans
    63. Johnson PN, Miller J, Gormley AK. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children. Pharmacotherapy. 2011 Jun; 31(6):609-20. PMID: 21923445.
      Citations: 1     Fields:    Translation:Humans
    64. Lewis TV, Johnson PN, Nebbia AM, Dunlap M. Increased enoxaparin dosing is required for obese children. Pediatrics. 2011 Mar; 127(3):e787-90. PMID: 21321026.
      Citations: 8     Fields:    Translation:Humans
    65. Gish EC, Harrison D, Gormley AK, Johnson PN. Dosing evaluation of continuous intravenous fentanyl infusions in overweight children: a pilot study. J Pediatr Pharmacol Ther. 2011 Jan; 16(1):39-46. PMID: 22477823.
      Citations:    
    66. Johnson PN, Harrison D, Allen C. Utility of transdermal fentanyl for prevention of iatrogenic opioid abstinence syndrome in children. J Opioid Manag. 2010 Mar-Apr; 6(2):117-24. PMID: 20481176.
      Citations: 1     Fields:    Translation:Humans
    67. Weant KA, Johnson PN, Bowers RC, Armitstead JA. Evidence-based, multidisciplinary approach to the development of a crotalidae polyvalent antivenin (CroFab) protocol at a university hospital. Ann Pharmacother. 2010 Mar; 44(3):447-55. PMID: 20124465.
      Citations: 3     Fields:    Translation:Humans
    68. Honey BL, Harrison DL, Gormley AK, Johnson PN. Evaluation of adverse events noted in children receiving continuous infusions of dexmedetomidine in the intensive care unit. J Pediatr Pharmacol Ther. 2010 Jan; 15(1):30-7. PMID: 22477790.
      Citations:    
    69. Miller JL, Allen C, Johnson PN. Neurologic withdrawal symptoms following abrupt discontinuation of a prolonged dexmedetomidine infusion in a child. J Pediatr Pharmacol Ther. 2010 Jan; 15(1):38-42. PMID: 22477791.
      Citations:    
    70. Gish EC, Miller JL, Honey BL, Johnson PN. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification. Ann Pharmacother. 2010 Feb; 44(2):343-51. PMID: 20040696.
      Citations: 19     Fields:    Translation:HumansAnimals
    71. Miller JL, Johnson PN, Harrison DL, Hagemann TM. Evaluation of inpatient admissions and potential antimicrobial and analgesic dosing errors in overweight children. Ann Pharmacother. 2010 Jan; 44(1):35-42. PMID: 20028958.
      Citations: 7     Fields:    Translation:Humans
    72. Miller JL, Gormley AK, Johnson PN. Pantoprazole-induced thrombocytopenia. Indian J Pediatr. 2009 Dec; 76(12):1278-9. PMID: 20012806.
      Citations: 3     Fields:    Translation:Humans
    73. Honey BL, Benefield RJ, Miller JL, Johnson PN. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother. 2009 Sep; 43(9):1506-11. PMID: 19690220.
      Citations: 11     Fields:    Translation:Humans
    74. Johnson PN, McGoodwin L, Banner W. Utilisation of Crotalidae polyvalent immune fab (ovine) for Viperidae envenomations in children. Emerg Med J. 2008 Dec; 25(12):793-8. PMID: 19033492.
      Citations: 1     Fields:    Translation:HumansAnimals
    75. Johnson PN, Kuhn RJ. Combination thrombolytic and anti-platelet therapies in an infant with incomplete kawasaki disease and coronary aneurysms. J Pediatr Pharmacol Ther. 2008 Oct; 13(4):242-50. PMID: 23055883.
      Citations:    
    76. Pesaturo KA, Ramsey EZ, Johnson PN, Taylor LM. Introduction to pediatric pharmacy practice: reflections of pediatrics practitioners. Am J Health Syst Pharm. 2008 Jul 15; 65(14):1314-9. PMID: 18593676.
      Citations: 1     Fields:    Translation:Humans
    77. Miller JL, Honey BL, Johnson PN, Hagemann TM. Effectiveness of trimethoprim/sulfamethoxazole for children with chronic active otitis media. Pediatrics. 2007 Dec; 120(6):1403; author reply 1403-4. PMID: 18055693.
      Citations: 4     Fields:    Translation:Humans
    78. Johnson PN, Rapp RP, Nelson CT, Butler JS, Overman S, Kuhn RJ. Characterization of community-acquired Staphylococcus aureus infections in children. Ann Pharmacother. 2007 Sep; 41(9):1361-7. PMID: 17652124.
      Citations: 2     Fields:    Translation:HumansCells
    79. Johnson PN, Rapp RP, Nelson CT, Butler JS, Overman S, Kuhn RJ. Utilizing Pharmacy Records to Assess Antibiotic Prescribing Patterns on the Incidence of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in Children. J Pediatr Pharmacol Ther. 2007 Apr; 12(2):91-101. PMID: 23055846.
      Citations:    
    80. Johnson PN, Smith KM. The teaching portfolio: a useful guide for pharmacists' teaching goals. Am J Health Syst Pharm. 2007 Feb 15; 64(4):352, 354, 356. PMID: 17299173.
      Citations:    Fields:    Translation:Humans
    81. Johnson PN, Romanelli F, Smith KM, Ranjan D, Butler JS, Clifford TM. Analysis of morbidity in liver transplant recipients following human albumin supplementation: a retrospective pilot study. Prog Transplant. 2006 Sep; 16(3):197-205. PMID: 17007153.
      Citations: 2     Fields:    Translation:Humans
    82. Johnson PN, Smith KM. Low-molecular-weight heparin use in special populations. Orthopedics. 2004 Dec; 27(12):1245-8. PMID: 15633954.
      Citations: 1     Fields:    Translation:Humans
    Johnson's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (223)
    Explore
    _
    Co-Authors (24)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _